Medications

Maker of Wegovy limits supply of obesity drug in US

Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.

Psychology & Psychiatry

Schools are key in tackling youth depression, review finds

School-based depression prevention programs may reduce the risk of depression diagnoses and depressive symptoms in K-12 students, according to new findings from University of Oregon researchers.

page 5 from 40